# A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1

> **NCT02572388** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 31 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** R21
- **BIOLOGICAL:** Matrix-M1

## Key facts

- **NCT ID:** NCT02572388
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-15
- **Primary completion:** 2017-08-29
- **Final completion:** 2017-08-29
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02572388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02572388, "A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02572388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*